Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. It even compensates for meconium interference in the neonatal gastrointestinal tract. Tune was also employed by Solvay, S. That no patient is harmed by undetected tissue hypoxia. Benni holds several patents on NIRS technology and authored several peer-reviewed journal articles on the topic. Prior to joining Novametrix, Mr.
|Date Added:||15 January 2009|
|File Size:||35.32 Mb|
|Operating Systems:||Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X|
|Price:||Free* [*Free Regsitration Required]|
Free Account Login Click here to access your premium account. CASM has been depressed for the last four months, and it has less to do with the underlying business than a casual glance might suggest.
CASM : Summary for CAS Medical Systems, Inc. – Yahoo Finance
Weisshaar spent 12 years as a corporate officer at Becton Dickinson and Company, a medical technology company where, at different times, he was responsible for global businesses in medical devices and diagnostic products and served as Chief Financial Officer and Vice President, Strategic Planning. Studies have shown that even relatively less serious hypoxic events may lengthen the duration on mechanical ventilation, time spent in the ICU, or overall stay.
Benni holds several patents on NIRS technology and authored several peer-reviewed journal articles on the topic. Gamelin John K Ph. In the first quarter of this year, Deerfield liquidated about half of their position, or 1, shares, on the open market.
While at Piper, she covered companies in the medical device, medical supply, and diagnostic areas. Weisshaar received a B.
One Equity Stocks encourages all readers to carefully review the SEC filings of any issuers we cover and consult with an investment professional before making any investment decisions. With this indictment, we think Deerfield is cleaning up Olan’s book.
Sensors tailored for patients of any size or age. One Equity Stocks has not been compensated to publish this article and has no relationship with the Company.
Although likely unknown to those not specializing in healthcare, the cerebral oximetry monitoring market is big. Market in 5 Minutes.
Why This $1.00 Medical Device Stock Is Set Up To Rip
This was basically a manufactured overhang. Rainey is a graduate of Loyola University with a B.
No hypoxic event is too small to go unnoticed. He graduated magna cum laude with a Vevice. Lastly, for longer term investors, there’s an even bigger opportunity in CASM.
CAS Medical Systems Inc (CASM.P)
Prior to attending graduate school, he worked as an engineer with GE Astrospace on satellites and the Mars Observer spacecraft. He formerly served on the boards of Orthofix International, N.
It may not be news to you, but a handful of Deerfield partners were recently indicted for insider trading. From to he served as Vice President of the vascular business as well as Vice President and G. Rainey was employed by Stryker Corporation where he held various sales management positions including the position of Vice President of Sales.
Tune was employed by Piper Jaffray Companies, where she was a health care analyst focused on medical technology companies.
CAS Medical Systems Inc (CASM.P) People |
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Weisshaar currently serves as a member of CenterLight Health System, a large non-profit nursing home and managed care organization located in the New York City area.
Milinazzo graduated cum laude from Boston College. There’s an easy explanation. The stock had been declining all year because PsiVida had their own overhang, a controlled equity financing agreement that let the company issue and sell new stock into the market.
In addition to being a board member of InspireMD, Inc. Baird was employed by Philips Medical Systems, Inc. Her educational background includes an M. Gamelin holds four U. He cadm an experienced senior executive and board director, developing high growth, profitable, global healthcare businesses, including biologics and dveice devices. When things get hairy, funds liquidate, deevice we think the Deerfield sales are just damage control in the office – not a result of the CASM fundamentals.